Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

EPIRUS Biopharmaceuticals, Inc. EPRSQ OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Chart & Stats

Market Data
52-Week Range1.0E-6-1.0E-4
Volume150
Market Cap$1.57K
Beta (1Y)-14.11
IPO Date2005-11-09
Employees73
CEOJeff Kagy
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS29428P1075

Price Chart

Track all markets on TradingView
EPRSQ
EPIRUS Biopharmaceuticals, Inc. ↗  ·  Other OTC
Healthcare • Biotechnology

People Also View

CNTA
CNTA
Centessa Pharmaceuticals plc
$39.59
+0.05%
 ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
 OPT
OPT
Opthea Limited
$3.41
+1.49%
 EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
 NAMSW
NAMSW
NewAmsterdam Pharma Company N.V.
$23.40
+0.00%
 PHVS
PHVS
Pharvaris N.V.
$28.68
+2.87%
 MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
 FBRX
FBRX
Forte Biosciences, Inc.
$32.42
+5.95%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message